BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6361134)

  • 1. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.
    Sauder DN; Mounessa NL; Katz SI; Dinarello CA; Gallin JI
    J Immunol; 1984 Feb; 132(2):828-32. PubMed ID: 6361134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
    Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
    Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.
    Luger TA; Charon JA; Colot M; Micksche M; Oppenheim JJ
    J Immunol; 1983 Aug; 131(2):816-20. PubMed ID: 6602848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
    Luger TA; Stadler BM; Luger BM; Mathieson BJ; Mage M; Schmidt JA; Oppenheim JJ
    J Immunol; 1982 May; 128(5):2147-52. PubMed ID: 6801132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic properties of epidermal cell thymocyte-activating factor (ETAF).
    Sauder DN
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):176s-179s. PubMed ID: 3874245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal cells synthesize a cytokine with interleukin 3-like properties.
    Luger TA; Wirth U; Köck A
    J Immunol; 1985 Feb; 134(2):915-9. PubMed ID: 3917479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epidermal cell-derived cytokine triggers the in vivo synthesis of serum amyloid A by hepatocytes.
    Sztein MB; Luger TA; Oppenheim JJ
    J Immunol; 1982 Jul; 129(1):87-90. PubMed ID: 7045226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal cell thymocyte-activating factor.
    Sauder DN
    Adv Dermatol; 1986; 1():237-46. PubMed ID: 3079245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotactic cytokines and inflammation. Biological properties of the lymphocyte and monocyte chemotactic factors ELCF, MCAF and IL-8.
    Zachariae CO
    Acta Derm Venereol Suppl (Stockh); 1993; 181():1-37. PubMed ID: 7901957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line.
    Luger TA; Stadler BM; Luger BM; Sztein MB; Schmidt JA; Hawley-Nelson P; Grabner G; Oppenheim JJ
    J Invest Dermatol; 1983 Sep; 81(3):187-93. PubMed ID: 6604110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1.
    Dinarello CA; Marnoy SO; Rosenwasser LJ
    J Immunol; 1983 Feb; 130(2):890-5. PubMed ID: 6401308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte chemotactic activity of human interleukin 1.
    Miossec P; Yu CL; Ziff M
    J Immunol; 1984 Oct; 133(4):2007-11. PubMed ID: 6332145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).
    Luger TA; Stadler BM; Katz SI; Oppenheim JJ
    J Immunol; 1981 Oct; 127(4):1493-8. PubMed ID: 6974195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal cytokines: properties of epidermal cell thymocyte-activating factor (ETAF).
    Sauder DN
    Lymphokine Res; 1984; 3(4):145-51. PubMed ID: 6208439
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.
    Gahring LC; Buckley A; Daynes RA
    J Clin Invest; 1985 Oct; 76(4):1585-91. PubMed ID: 2997285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokines: their role in lymphocyte responses. Properties of interleukin 1.
    Oppenheim JJ; Stadler BM; Siraganian RP; Mage M; Mathieson B
    Fed Proc; 1982 Feb; 41(2):257-62. PubMed ID: 6800841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse.
    Granstein RD; Margolis R; Mizel SB; Sauder DN
    J Clin Invest; 1986 Mar; 77(3):1020-7. PubMed ID: 3512598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulation using an epidermal cytokine (ETAF)].
    Luger TA; Niebauer G
    Z Hautkr; 1984 Jan; 59(1):18, 23-34. PubMed ID: 6367244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidermal cell derived thymocyte activating factor or ETAF: an interleukin secreted by epidermal cells].
    Penso D
    Ann Dermatol Venereol; 1986; 113(2):153-7. PubMed ID: 3487268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.